The US-based foundation Fighting Blindness has pledged to fund vision research at Radboudumc and the Donders Institute with a total sum of five million dollars. The funds will be used to develop therapies for hereditary diseases of the retina and Usher syndrome.There are thousands of children and adults in the Netherlands affected by hereditary diseases of the retina. These are conditions for which - until this day - treatment is elusive. At Radboudumc and the Donders Institute, several research groups are working to develop new therapies with which these conditions can be treated.
The first project is a collaboration between the departments of genetics, ENT, and opthalmology, and aims to find genetic errors that lead to abnormalities in messenger RNA (mRNA). Frans Cremers, professor of Blindness Genetics and coordinator of the project: "mRNA translates DNA to proteins. We developed a 'genetic bandaid' that can patch errors in mRNA, which leads them to produce functioning proteins again. With the new funding we are going to improve this technique and test it in animal models. Thereby, we hope to eventually develop experimental treatments for patients suffering from retinitis pigmentosa, Stargardt's disease, and Usher syndrome. These are all diseases where these types of genetic errors occur."
In the second project, the department of Genetics will collaborate with universities in London, Mainz, and Tübingen. Work in cells, and thus also in the retinal cells in the eye, is performed by proteins. To perform its various duties, every cell maintains a dynamic balance of different active proteins. "We want to unravel the mechanisms by which the amount of active proteins is regulated within a retinal cell", says Ronald Roepman, professor of Genetics and coordinator of this project. "This regulation is disturbed in hereditary diseases of the eye. The knowledge that we are going to obtain can be used to develop medication to counter counter these disturbances. This way, we aim to stop the progression of blindness in patients".
Two out of three
The US-based faoundation Fighting Blindness has approved a total of three of these large funds this year, of which two were awarded to research groups in Nijmegen.
Related news items
KWF Roadshow 11 November 201910 October 2019
In which way(s) can KWF provide optimal support to oncological research and care? How can we maximize impact on our investments? These questions are pivotal in Ambition 2030: the vision that KWF developed in close cooperation with stakeholders in the oncological field.read more
More than 3000 visitors at Open Day RIHS10 October 2019
On Sunday 6 October RIHS organized an Open Day in the Weekend of Science (“Weekend van de Wetenschap”) with special guest and television presenter Klaas van Kruistum. More than 3000 visitors became a health scientist for one day and discovered how special healthcare research is.read more
Dorine Swinkels collaborates with winners of the Nobel Prize in Physiology or Medicine9 October 2019
The Nobel Prize in Physiology or Medicine 2019 was awarded jointly to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza for their discoveries of how cells sense and adapt to oxygen availability.read more
Scaling up nanotherapy7 October 2019
Scaling up and translating nanotherapy from pre-clinical work in small animal models to a clinical application is not trivial. Raphael Duivenvoorden, theme Renal disorders, and colleagues, published their results on translating a new nanoimmunotherapy in the journal Science Translational Medicine.read more
‘Smart shirt’ can accurately measure breathing and could be used to monitor lung disease3 October 2019
Denise Mannée and colleagues are developing Hexoskin, a smart shirt that can measure breathing in people. It can reliably measure breathing in healthy people while carrying out activities. This means they can now test out the smart shirts with patients who have COPD.read more